STOCK TITAN

[144] Bitwise MARA Option Income Strategy ETF SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Form 144 notice for proposed sale of securities. The filing reports an intended sale of 5,250 common shares through Jefferies LLC on 08/27/2025, with an aggregate market value of $106,680.00. The securities were acquired on 08/09/2022 via stock options from Enliven Therapeutics. The filer reports 59,000,000 shares outstanding. The filing also discloses four prior sales by Benjamin Hohl totaling 10,500 shares on dates in June and July 2025 with the recorded gross proceeds for each sale.

Avviso Form 144 relativo a una proposta di vendita di titoli. La comunicazione segnala l'intenzione di vendere 5.250 azioni ordinarie tramite Jefferies LLC in data 27/08/2025, per un valore di mercato complessivo di $106.680,00. I titoli sono stati acquisiti il 09/08/2022 attraverso opzioni su azioni di Enliven Therapeutics. Il dichiarante riporta un totale di 59.000.000 azioni in circolazione. La segnalazione riporta inoltre quattro vendite precedenti effettuate da Benjamin Hohl per un totale di 10.500 azioni, avvenute tra giugno e luglio 2025, con i proventi lordi registrati per ciascuna vendita.

Aviso Form 144 sobre la venta propuesta de valores. La presentación informa la intención de vender 5.250 acciones ordinarias a través de Jefferies LLC el 27/08/2025, por un valor de mercado agregado de $106.680,00. Los valores fueron adquiridos el 09/08/2022 mediante opciones sobre acciones de Enliven Therapeutics. El declarante informa 59.000.000 acciones en circulación. El informe también divulga cuatro ventas previas realizadas por Benjamin Hohl que suman 10.500 acciones en fechas de junio y julio de 2025, con los ingresos brutos registrados para cada venta.

증권 매도 예정에 대한 Form 144 통지. 제출서류는 2025-08-27Jefferies LLC를 통해 5,250 보통주 매도를 계획했다고 보고하며, 총 시가 가치는 $106,680.00입니다. 해당 증권은 2022-08-09Enliven Therapeutics의 주식옵션을 통해 취득되었습니다. 제출인은 총 발행주식 수를 59,000,000주로 보고합니다. 또한 보고서에는 Benjamin Hohl이 2025년 6월과 7월에 각각 기록된 총매도대금과 함께 매도한 10,500주의 네 건의 이전 매도가 공개되어 있습니다.

Avis Form 144 concernant une vente proposée de titres. Le dépôt signale l'intention de vendre 5 250 actions ordinaires via Jefferies LLC le 27/08/2025, pour une valeur de marché globale de $106 680,00. Les titres ont été acquis le 09/08/2022 par le biais d'options sur actions de Enliven Therapeutics. Le déclarant indique 59 000 000 d'actions en circulation. Le dossier divulgue également quatre ventes antérieures effectuées par Benjamin Hohl totalisant 10 500 actions aux dates de juin et juillet 2025, avec les produits bruts enregistrés pour chaque vente.

Form 144-Mitteilung über geplanten Wertpapierverkauf. Die Einreichung meldet den beabsichtigten Verkauf von 5.250 Stammaktien über Jefferies LLC am 27.08.2025 mit einem Gesamtmarktwert von $106.680,00. Die Wertpapiere wurden am 09.08.2022 durch Aktienoptionen von Enliven Therapeutics erworben. Der Melder gibt 59.000.000 ausstehende Aktien an. Die Einreichung offenbart außerdem vier frühere Verkäufe von Benjamin Hohl in den Monaten Juni und Juli 2025 über insgesamt 10.500 Aktien, mit den für jeden Verkauf verzeichneten Bruttoerlösen.

Positive
  • Complete Rule 144 disclosure including broker, class, amount, acquisition date, and acquisition method
  • Recent sales disclosed with dates and gross proceeds, improving transparency
Negative
  • Insider executed multiple sales totaling 10,500 shares in the past three months (June–July 2025)

Insights

TL;DR: Routine Rule 144 disclosure of an officer/affiliate sale; provides required transaction and acquisition detail.

The filing supplies the standard elements required by Rule 144: identity of broker (Jefferies LLC), class, amount to be sold (5,250 shares), acquisition method (stock options on 08/09/2022), and recent sales activity by the same person (10,500 shares sold across June–July 2025). It also states the number of shares outstanding (59,000,000) and the proposed sale date (08/27/2025), which are material for resale volume calculations under Rule 144. The submission includes the signer’s representation regarding material nonpublic information.

TL;DR: Disclosure is complete for a Section 144 notice; recent sales are documented but no adverse events disclosed.

The notice documents recent insider sales by an identified individual and the planned transaction through a named broker. It contains acquisition details (stock options) and demonstrates compliance with Rule 144 timing and disclosure requirements. The filing does not include any commentary on motives, internal trading plans, or additional governance actions. No material adverse information is asserted in the remarks.

Avviso Form 144 relativo a una proposta di vendita di titoli. La comunicazione segnala l'intenzione di vendere 5.250 azioni ordinarie tramite Jefferies LLC in data 27/08/2025, per un valore di mercato complessivo di $106.680,00. I titoli sono stati acquisiti il 09/08/2022 attraverso opzioni su azioni di Enliven Therapeutics. Il dichiarante riporta un totale di 59.000.000 azioni in circolazione. La segnalazione riporta inoltre quattro vendite precedenti effettuate da Benjamin Hohl per un totale di 10.500 azioni, avvenute tra giugno e luglio 2025, con i proventi lordi registrati per ciascuna vendita.

Aviso Form 144 sobre la venta propuesta de valores. La presentación informa la intención de vender 5.250 acciones ordinarias a través de Jefferies LLC el 27/08/2025, por un valor de mercado agregado de $106.680,00. Los valores fueron adquiridos el 09/08/2022 mediante opciones sobre acciones de Enliven Therapeutics. El declarante informa 59.000.000 acciones en circulación. El informe también divulga cuatro ventas previas realizadas por Benjamin Hohl que suman 10.500 acciones en fechas de junio y julio de 2025, con los ingresos brutos registrados para cada venta.

증권 매도 예정에 대한 Form 144 통지. 제출서류는 2025-08-27Jefferies LLC를 통해 5,250 보통주 매도를 계획했다고 보고하며, 총 시가 가치는 $106,680.00입니다. 해당 증권은 2022-08-09Enliven Therapeutics의 주식옵션을 통해 취득되었습니다. 제출인은 총 발행주식 수를 59,000,000주로 보고합니다. 또한 보고서에는 Benjamin Hohl이 2025년 6월과 7월에 각각 기록된 총매도대금과 함께 매도한 10,500주의 네 건의 이전 매도가 공개되어 있습니다.

Avis Form 144 concernant une vente proposée de titres. Le dépôt signale l'intention de vendre 5 250 actions ordinaires via Jefferies LLC le 27/08/2025, pour une valeur de marché globale de $106 680,00. Les titres ont été acquis le 09/08/2022 par le biais d'options sur actions de Enliven Therapeutics. Le déclarant indique 59 000 000 d'actions en circulation. Le dossier divulgue également quatre ventes antérieures effectuées par Benjamin Hohl totalisant 10 500 actions aux dates de juin et juillet 2025, avec les produits bruts enregistrés pour chaque vente.

Form 144-Mitteilung über geplanten Wertpapierverkauf. Die Einreichung meldet den beabsichtigten Verkauf von 5.250 Stammaktien über Jefferies LLC am 27.08.2025 mit einem Gesamtmarktwert von $106.680,00. Die Wertpapiere wurden am 09.08.2022 durch Aktienoptionen von Enliven Therapeutics erworben. Der Melder gibt 59.000.000 ausstehende Aktien an. Die Einreichung offenbart außerdem vier frühere Verkäufe von Benjamin Hohl in den Monaten Juni und Juli 2025 über insgesamt 10.500 Aktien, mit den für jeden Verkauf verzeichneten Bruttoerlösen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for IMRA report?

The filing reports a proposed sale of 5,250 common shares through Jefferies LLC on 08/27/2025 with aggregate market value $106,680.00.

Who acquired the securities being sold and how?

The securities were acquired on 08/09/2022 via stock options from Enliven Therapeutics.

How many shares outstanding does the filing state?

The filing lists 59,000,000 shares outstanding.

Were there recent sales by the same person before this filing?

Yes. Benjamin Hohl sold 3,000 shares on 06/13/2025, 3,250 on 06/27/2025, 1,000 on 07/10/2025, and 3,250 on 07/28/2025 (total 10,500 shares).

Which broker is named to execute the proposed sale?

Jefferies LLC, 520 Madison Ave, 4th Fl, New York, NY 10022, is listed as the broker.

Does the filing state any material nonpublic information?

The signer represents they do not know any material adverse information that has not been publicly disclosed.
Bitwise MARA Option Income Strategy ETF

NYSE:IMRA

IMRA Rankings

IMRA Latest News

IMRA Latest SEC Filings

IMRA Stock Data

140.00k
Pharmaceutical Preparations
BOULDER